233 related articles for article (PubMed ID: 7307849)
1. The value of combination of bone scanning and measurement of carcinoembryonic antigen in diagnosis of breast cancer metastases.
Kausitz J; Makaiová I; Hupka S; Vivodová M
Czech Med; 1981; 4(3):159-62. PubMed ID: 7307849
[TBL] [Abstract][Full Text] [Related]
2. The status of nuclear medicine techniques in the diagnosis of bone metastases in breast cancer.
Makaiová I; Kausitz J; Hupka S; Michaliková B; Vivodová M; Bohunický L
Czech Med; 1989; 12(1):34-9. PubMed ID: 2498049
[TBL] [Abstract][Full Text] [Related]
3. [Correlation of the results of gammagraphic study of the skeleton with the level of carcinoembryonic antigen and tissue polypeptide antigen in breast cancer].
Makaiová I; Kausitz J; Hupka S; Michalíková B; Vivodová M; Simko S; Urbanová M; Bohunický L
Cesk Radiol; 1986 May; 40(3):157-61. PubMed ID: 3719846
[No Abstract] [Full Text] [Related]
4. [Carcinoma of the breast: diagnosis of sub-clinical bone metastases. Predictive value of isotope bone scan (author's transl)].
Calle R; Gongora R; Vilcoq JR; Desprez P; Schlienger P
Bull Cancer; 1980; 67(3):313-7. PubMed ID: 7407429
[TBL] [Abstract][Full Text] [Related]
5. [Is preoperative bone scintigraphy in early stage of breast cancer T1N0 indicated and meaningful?].
Žaloudík J; Skovajsová M; Česlarová K; Bieberová L; Hussarová L; Zimovjanová M; Petruželka L
Klin Onkol; 2013; 26(6):443-7. PubMed ID: 24320594
[TBL] [Abstract][Full Text] [Related]
6. [Bone scintigraphy in the preoperative determination of the stage of breast cancer].
Denisov LE; Iarygin LM; Ermolaeva EV; Zhuravleva LI
Med Radiol (Mosk); 1984 Jul; 29(7):5-8. PubMed ID: 6087080
[TBL] [Abstract][Full Text] [Related]
7. Comparison of bone scanning and CA 15-3 serum concentration in the follow-up of breast cancer.
Montravers F; Younsi N; Rousseau C; Philippe C; Seddiki M; Uzan S; Izrael V; Talbot JN
Anticancer Res; 1997; 17(3B):1683-6. PubMed ID: 9179218
[TBL] [Abstract][Full Text] [Related]
8. Single determination of CA 15.3 and bone scintigraphy in the diagnosis of skeletal metastases of breast cancer.
Crippa F; Bombardieri E; Seregni E; Castellani MR; Gasparini M; Maffioli L; Pizzichetta M; Buraggi GL
J Nucl Biol Med (1991); 1992; 36(1):52-5. PubMed ID: 1450226
[TBL] [Abstract][Full Text] [Related]
9. [The value of routine bone scintigraphy in primary operable breast cancer].
Thomsen HS; Munck O; Andersen KW
Ugeskr Laeger; 1984 Jun; 146(26):1915-8. PubMed ID: 6506284
[No Abstract] [Full Text] [Related]
10. Correlation between bone scintigraphy and tumor markers in patients with breast carcinoma.
Begić A; Kucukalić-Selimović E; Obralić N; Durić O; Lacević N; Skopljak A
Bosn J Basic Med Sci; 2006 Feb; 6(1):75-7. PubMed ID: 16533185
[TBL] [Abstract][Full Text] [Related]
11. "Role of bone scintigraphy in the management of patients with carcinoma of breast".
Krishna BA
Indian J Cancer; 1982 Mar; 19(1):47-51. PubMed ID: 7106833
[No Abstract] [Full Text] [Related]
12. [Skeletal scintigraphy in the care of breast cancer . Long-term follow-up over 8 years].
Anger K; Möller T; Zeimantz E
Strahlentherapie; 1983 Dec; 159(12):745-50. PubMed ID: 6665812
[TBL] [Abstract][Full Text] [Related]
13. Type I collagen biomarkers in the diagnosis of bone metastases in breast cancer, lung cancer, urinary bladder cancer and prostate cancer. Comparison to CEA, CA 15-3, PSA and bone scintigraphy.
Zissimopoulos A; Stellos K; Matthaios D; Petrakis G; Parmenopoulou V; Babatsikou F; Matthaiou E; Theodosiadou E; Hountis P; Koutis C
J BUON; 2009; 14(3):463-72. PubMed ID: 19810140
[TBL] [Abstract][Full Text] [Related]
14. Association between bone scintigraphy and serum levels of tumor markers in the detection of bone disease in breast cancer patients.
Zissimopoulos A; Matthaios D; Matthaiou E; Mantadakis E; Karaitianos I
J BUON; 2007; 12(4):505-11. PubMed ID: 18067209
[TBL] [Abstract][Full Text] [Related]
15. [Clinical efficacy of bone scintigraphy for metastatic bone tumors].
Nakajima T; Sugiyama S; Yamakawa M
Rinsho Hoshasen; 1983 May; 28(5):579-83. PubMed ID: 6887613
[No Abstract] [Full Text] [Related]
16. Role of bone scanning in carcinoma of the breast.
Nolan NG; Koppikar MM; Kotlyarov EV
Ann Clin Lab Sci; 1980; 10(2):105-10. PubMed ID: 6992693
[TBL] [Abstract][Full Text] [Related]
17. [Diagnostic value of whole-body MRI and bone scintigraphy in the detection of osseous metastases in patients with breast cancer--A Prospective Double-Blinded Study at two Hospital Centers].
Ohlmann-Knafo S; Kirschbaum M; Fenzl G; Pickuth D
Rofo; 2009 Mar; 181(3):255-63. PubMed ID: 19229791
[TBL] [Abstract][Full Text] [Related]
18. The informative content of radiography and scintigraphy in the diagnosis of bone metastases after breast cancer.
Sulman C; Sailly JC; Demaille MC; Eeckhoudt L; Carpentier P; Vennin P; Lebrun T
Soc Sci Med; 1985; 21(10):1181-5. PubMed ID: 4081819
[TBL] [Abstract][Full Text] [Related]
19. [Is bone scan useful in patients with breast cancer localized on the basis of clinical examination. 143 cases (author's transl)].
Stines J; Stalars J; Dartois D; Chardot C
Bull Cancer; 1980; 67(3):319-23. PubMed ID: 7407430
[TBL] [Abstract][Full Text] [Related]
20. [The value of skeletal scintigraphy in the aftercare of breast carcinoma. A prospective study of 750 cases].
Schünemann H; Jourdain M
Dtsch Med Wochenschr; 1989 Jan; 114(1):3-8. PubMed ID: 2535982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
